These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 14630539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.
    Dittmann K, Mayer C, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2008 Mar; 86(3):375-82. PubMed ID: 18237807
    [Abstract] [Full Text] [Related]

  • 4. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW, Donahue JJ, Wan XS.
    Nutr Cancer; 1996 Mar; 26(2):209-17. PubMed ID: 8875558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The radioprotective effect of BBI is associated with the activation of DNA repair-relevant genes.
    Dittmann KH, Gueven N, Mayer C, Rodemann HP.
    Int J Radiat Biol; 1998 Aug; 74(2):225-30. PubMed ID: 9712551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protection against adverse biological effects induced by space radiation by the Bowman-Birk inhibitor and antioxidants.
    Kennedy AR, Zhou Z, Donahue JJ, Ware JH.
    Radiat Res; 2006 Aug; 166(2):327-32. PubMed ID: 16881733
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
    Billings PC, Habres JM, Liao DC, Tuttle SW.
    Cancer Res; 1991 Oct 15; 51(20):5539-43. PubMed ID: 1913672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.
    Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, Halbrook J, Kesicki EA, Kashishian A, Hallahan DE.
    Cancer Res; 2005 Jun 15; 65(12):4987-92. PubMed ID: 15958537
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.
    Neurourol Urodyn; 2003 Jun 15; 22(1):54-7. PubMed ID: 12478602
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H, Kennedy AR, Witschi H, Shen WC.
    J Drug Target; 1993 Jun 15; 1(1):41-9. PubMed ID: 8069543
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.